{ "items" : [
    { "id" : "http://dbpedia.org/resource/Abraxis_BioScience"
      "properties" : {
        "http://www.w3.org/2000/01/rdf-schema#comment" : [ "Abraxis BioScience is a global biopharmaceutical company dedicated to meeting the needs of critically ill patients, with over 2000 employees worldwide.  Abraxis' portfolio includes the world's first protein-based nanoparticle chemotherapeutic compound called nab Technology. From this the company has developed Abraxane, a treatment for metastatic breast cancer.  On June 30, 2010, it was announced that Abraxis BioScience would be acquired by Celgene Corporation."] } } }
